Vanderbilt-ingram Cancer Center

This study tests whether adding rigosertib to pembrolizumab can help people with advanced melanoma that did not respond to previous immunotherapy. Rigosertib may block cancer cell growth and make the immune system more responsive to pembrolizumab. The trial enrolled 7 adults with…

This study tests whether an artificial intelligence (AI) tool called the Virtual Nodule Clinic can help doctors better manage lung nodules that are not clearly cancerous or benign. The AI analyzes CT scans and patient information to estimate the risk of cancer. The goal is to see…

This study looks at ways to help people who have genetic test results for inherited cancer risks. The goal is to see if certain interventions can help them follow cancer prevention guidelines and share their results with family members. The study includes 720 adults with specific…

This study follows 45 uninsured current or former smokers to find early signs of lung cancer. Researchers use CT scans, lab tests, and medical records to spot cancer sooner. The goal is to improve early detection in a group that often lacks access to screening.

This study looks at a new way to combine different tests (biomarkers) to better tell if a lung spot (nodule) is cancer or not. The goal is to help doctors avoid unnecessary invasive procedures for people with harmless nodules. 103 adults with medium-risk lung nodules are taking p…